Keywords: آنتی ژن اختصاصی پروستات; Cancer biomarker; Capillary conditioning; Capillary electrophoresis; Isoform; Prostate specific antigen; PSA
مقالات ISI آنتی ژن اختصاصی پروستات (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: آنتی ژن اختصاصی پروستات; prostatic neoplasms; prostate-specific antigen; early detection of cancer; government agencies; biopsy; needle; AUA; American Urological Association; AUASS; AUA symptom score; CAPRA; Cancer of the Prostate Risk Assessment; PCa; prostate cancer; PCP; prima
Keywords: آنتی ژن اختصاصی پروستات; prostatic neoplasms; biological markers; sensitivity and specificity; prostate-specific antigen; risk; AS; active surveillance; BCR; biochemical recurrence; CAPRA-S; Cancer of the Prostate Risk Assessment Postsurgical; CCP; cell cycle progression; DRE; di
Keywords: آنتی ژن اختصاصی پروستات; prostatic neoplasms; genomics; biological assay; prostatectomy; watchful waiting; AP; adverse pathology; AS; active surveillance; CAPRA; Cancer of the Prostate Risk Assessment; GPS; Genomic Prostate Score; LFP; likelihood of favorable pathology; LIR; low
Keywords: آنتی ژن اختصاصی پروستات; BMI; Body mass index; CI; Confidence interval; PCa; Prostate cancer; PSA; Prostate specific antigen; PR; Prevalence ratio; RCT; Randomized clinical trial; SES; Socioeconomic status; SRH; Self-rated health; SHIS; Swiss Health Interview Survey; PSA; Trends;
Keywords: آنتی ژن اختصاصی پروستات; AB; alpha-adrenergic blocker; BPH; benign prostatic hyperplasia; 5-ARI; 5-alpha reductase inhibitor; LUTS; lower urinary tract symptom; PCPT; Prostate Cancer Prevention Trial; PSA; prostate specific antigen; SHR; subdistribution hazard ratio;
Keywords: آنتی ژن اختصاصی پروستات; 2-AB; 2-aminobanzamide; AFP; α-fetoprotein; AGP; α1-acid glycoprotein; BMI; body mass index; CDG; congenital disorders of glycosylation; CEA; carcinoembryonic antigen; CRP; C-reactive protein; CVD; cardiovascular disease; DAS28; Disease Activity Score b
Keywords: آنتی ژن اختصاصی پروستات; Biomarkers; Glycosylation; Lectin-based immunoassay; Prostate cancer; Prostate specific antigen
Keywords: آنتی ژن اختصاصی پروستات; prostatectomy; risk; prostatic neoplasms; biopsy; watchful waiting; EPE; extraprostatic extension; GS; Gleason score; IPBx; initial prostate biopsy; LR; low risk; NCCN®; National Comprehensive Cancer Network®; PCa; prostate cancer; PSA; prostate specifi
Keywords: آنتی ژن اختصاصی پروستات; Kallikrein-related peptidase; KLK; Cancer; Function; Protease; Carcinogenesis; AR; androgen receptor; B2R; kinin receptor B2; BMP; bone morphogenic protein; CDH; cadherin; DHT; dihydrotestosterone; DNA; deoxyribonucleic Acid; Dsg; desmoglein; ECM; extrace
Keywords: آنتی ژن اختصاصی پروستات; prostate; adenocarcinoma; biopsy; magnetic resonance imaging; ultrasound, high-intensity focused, transrectal; CDR; cancer detection rate; DCE; dynamic contrast enhanced; FB; fusion guided biopsy; LIJ; Long Island Jewish Medical Center; MP; multiparametri
Keywords: آنتی ژن اختصاصی پروستات; watchful waiting; prostatic neoplasms; eligibility determination; AS; active surveillance; B2; confirmatory biopsy (second biopsy); BCR; biochemical recurrence; GS; Gleason score; JH; Johns Hopkins; MSK; Memorial Sloan Kettering Cancer Center; PCa; prosta
Keywords: آنتی ژن اختصاصی پروستات; prostatic neoplasms; neoplasm grading; tumor burden; neoplasm invasiveness; watchful waiting; AS; active surveillance; BCR; biochemical recurrence; EPE; extraprostatic extension; GG; Grade Group; GS; Gleason score; PCa; prostate cancer; PSA; prostate spec
Keywords: آنتی ژن اختصاصی پروستات; hypogonadism; testosterone; energy; libido; AE; adverse event; BMI; body mass index; CV; cardiovascular; HbA1c; hemoglobin A1c; HED; Hypogonadism Energy Diary; I-PSS; International Prostate Symptom Score; LC-MS/MS; liquid chromatography tandem mass spect
Keywords: آنتی ژن اختصاصی پروستات; prostatic neoplasms; African Americans; watchful waiting; neoplasm staging; neoplasm grading; AA; African-American; BCR; biochemical recurrence; CAPRA-S; Cancer of the Prostate Risk Assessment; JHU; Johns Hopkins University; PCa; prostate cancer; PSA; pro
Keywords: آنتی ژن اختصاصی پروستات; prostatic neoplasms; biopsy; elasticity imaging techniques; diagnostic imaging; predictive value of tests; ACC; accuracy; ELA; elastography; NPV; negative predictive value; PCa; prostate cancer; PPV; positive predictive value; PSA; prostate specific antig
Keywords: آنتی ژن اختصاصی پروستات; neoplasms; prostate; prostatic neoplasms; watchful waiting; treatment outcome; AS; active surveillance; MRI; magnetic resonance imaging; MUSIC; Michigan Urological Surgery Improvement Collaborative; NCCN®; National Comprehensive Cancer Network®; PSA; pr
Keywords: آنتی ژن اختصاصی پروستات; prostatic neoplasms; watchful waiting; anxiety; uncertainty; questionnaires; AS; active surveillance; PSA; prostate specific antigen;
Keywords: آنتی ژن اختصاصی پروستات; prostate; prostatic hyperplasia; urinary retention; inflammation; disease progression; AUR; acute urinary retention; BMI; body mass index; BPE; benign prostatic enlargement; BPH; benign prostatic hyperplasia; LUTS; lower urinary tract symptoms; PSA; prost
Keywords: آنتی ژن اختصاصی پروستات; prostatic neoplasms; prognosis; community health services; recurrence; genomics; CAPRA-S; Cancer of the Prostate Risk Assessment Post-Surgical; KPNW; Kaiser Permanente Northwest; PSA; prostate specific antigen;
Keywords: آنتی ژن اختصاصی پروستات; Biochemical recurrence; Circulating tumor cells; Prostate cancer; Prostate specific antigen; PSA doubling times
Keywords: آنتی ژن اختصاصی پروستات; prostate; prostate-specific antigen; malpractice; liability; legal; guidelines as topic; AAFP; American Academy of Family Physicians; AUA; American Urological Association; PCP; primary care physician; PSA; prostate specific antigen; USPSTF; United States
Keywords: آنتی ژن اختصاصی پروستات; lymph node excision; treatment outcome; quality of health care; prostatectomy; robotics; LND; lymph node dissection; NCDB; National Cancer Data Base; ORP; open radical prostatectomy; PCa; prostate cancer; PLND; pelvic lymph node dissection; PSA; prostate
Keywords: آنتی ژن اختصاصی پروستات; prostatic neoplasms; neoplasm metastasis; neoplasms; multiple primary; mortality; prognosis; ECOG; Eastern Cooperative Oncology Group; mPCa; metastatic PCa; OS; overall survival; PCa; prostate cancer; PSA; prostate specific antigen; RT; radiation therapy;
Keywords: آنتی ژن اختصاصی پروستات; prostatic neoplasms; radiotherapy; neoplasm recurrence; local; salvage therapy; prostate-specific antigen; ADT; androgen deprivation therapy; ASTRO; American Society for Radiation Oncology; BCR; biochemical recurrence; EBRT; external beam radiation therap
Keywords: آنتی ژن اختصاصی پروستات; Digital rectal examination; Oncology; Prostate cancer; Prostate specific antigen; Transrectal-ultrasound; Biopsy
Keywords: آنتی ژن اختصاصی پروستات; prostatic neoplasms; prostatectomy; prostate-specific antigen; neoplasm recurrence; local; diagnosis; ART; adjuvant RT; BCR; biochemical relapse; cBCR; conventional BCR; iPSA; initial PSA; PSA; prostate specific antigen; RP; radical prostatectomy; RT; rad
Keywords: آنتی ژن اختصاصی پروستات; prostatic neoplasms; delivery of health care; urology; prostate-specific antigen; patient safety; KP; Kaiser Permanente; KPSC; Kaiser Permanente Southern California; PCa; prostate cancer; PSA; prostate specific antigen;
Keywords: آنتی ژن اختصاصی پروستات; Prostate cancer; Mortality; prostate specific antigen; digital rectal examination; co-morbidity;
Keywords: آنتی ژن اختصاصی پروستات; prostatic neoplasms; prostate specific antigen; radionuclide imaging; neoplasm metastasis; physician's practice patternsADT, androgen deprivation therapy; CRPC, castration resistant prostate cancer; M0, nonmetastatic; PC, prostate cancer; PSADT, PSA doubl
Keywords: آنتی ژن اختصاصی پروستات; AUC; area under the ROC curve; BIC; Bayesian information criterion; DRE; digital rectal exam; EMR; electronic medical record; HLS; Hosmer-Lemeshow test statistic; MCMC; Markov Chain Monte Carlo; PBCG; prostate biopsy collaborative group; PCPT; prostate
Keywords: آنتی ژن اختصاصی پروستات; blood glucose; diabetes mellitus; prostate-specific antigen; AER; albumin excretion rate; BMI; body mass index; DCCT; Diabetes Control and Complications Trial; EDIC; Epidemiology of Diabetes Interventions and Complications study; HbA1c; hemoglobin A1c; PC
Keywords: آنتی ژن اختصاصی پروستات; prostatic neoplasms; biological markers; risk assessment; molecular diagnostic techniques; ADT; androgen deprivation therapy; AS; active surveillance; Columbia; New York-Presbyterian Hospital, Columbia University; DVU; Delaware Valley Urology, LLC; EBRT;
Keywords: آنتی ژن اختصاصی پروستات; prostatic neoplasms; gonadotropin-releasing hormone; physician's practice patterns; neoplasm recurrence; local; neoplasm metastasis; ADT; androgen deprivation therapy; CADT; continuous androgen deprivation therapy; GnRH; gonadotropin-releasing hormone; IA
Keywords: آنتی ژن اختصاصی پروستات; Circulating tumor cells; Prostate cancer; Tumor biomarkers; Prognosis; Prostate specific antigen;
Keywords: آنتی ژن اختصاصی پروستات; Prostate specific antigen; Nano-iniferter; MWCNTs; Mn nanoparticle; Surface imprinting; Real sample.;
Keywords: آنتی ژن اختصاصی پروستات; hematuria; prostatic neoplasms; radiotherapy; urethral stricture; urinary bladder neoplasms; BCa; bladder cancer; BT; brachytherapy; EBRT; external beam radiation therapy; EBRT+BT; combination radiation therapy; PCa; prostate cancer; PSA; prostate specifi
Keywords: آنتی ژن اختصاصی پروستات; Prostate cancer; Prostate specific antigen; Screening;
Keywords: آنتی ژن اختصاصی پروستات; Prostate specific antigen; Prostate specific antigen velocity; Gleason score;
Keywords: آنتی ژن اختصاصی پروستات; prostatic neoplasms; castration-resistant; ADT; androgen deprivation therapy; AUA; American Urological Association; CRPC; castration resistant prostate cancer; FDA; Food and Drug Administration; mCRPC; metastatic castration resistant prostate cancer; PSA;
Keywords: آنتی ژن اختصاصی پروستات; prostate; prostate-specific antigen; cryosurgery; disease progression; mortality; ASTRO; American Society for Therapeutic Radiology and Oncology; BPFS; biochemical progression-free survival; COLD; Cryo On-Line Database; PSA; prostate specific antigen;
Keywords: آنتی ژن اختصاصی پروستات; prostate; biopsy; pathology; laboratories; conflict of interest; DRE; digital rectal examination; ISL; independent service laboratory; PSA; prostate specific antigen; UOL; urologist owned pathology laboratory;
Keywords: آنتی ژن اختصاصی پروستات; prostate; prostatic neoplasms; prostate-specific antigen; mass screening; practice guidelines as topic; ACP; American College of Physicians; AUA; American Urological Association; PCP; primary care physician; PSA; prostate specific antigen; USPSTF; United
Keywords: آنتی ژن اختصاصی پروستات; CSE; Clinical Skin Examination; FOBT; Faecal Occult Blood Test; GP; General Practitioner; PSA; Prostate Specific Antigen; SAMScore; Self-Assessment of Melanoma risk Score; Melanoma; Screening; Patient compliance; Clinical pathway; Health belief model;
Keywords: آنتی ژن اختصاصی پروستات; prostate; prostatic neoplasms; prostatectomy; neoplasm recurrence; local; neoplasm grading; BCR; biochemical recurrence; EPE; extraprostatic extension; LNI; lymph node invasion; PSA; prostate specific antigen; PSM; positive surgical margin; RP; radical pr
Keywords: آنتی ژن اختصاصی پروستات; prostate; hydroxymethylglutaryl-coA reductase inhibitors; prostatic neoplasms; risk; mass screening; BMI; body mass index; NSAID; nonsteroidal anti-inflammatory drug; PCPT; Prostate Cancer Prevention Trial; PSA; prostate specific antigen;
Keywords: آنتی ژن اختصاصی پروستات; prostate; prostatic neoplasms; biopsy; physician's practice patterns; Michigan; DRE; digital rectal examination; MUSIC; Michigan Urological Surgery Improvement Collaborative; PCa; prostate cancer; PSA; prostate specific antigen; TRUS; transrectal ultrasou
Keywords: آنتی ژن اختصاصی پروستات; prostate-specific antigen; ancillary services; hospital; jurisprudence; urology; physicians; primary care; IOAS; in-office ancillary services; NAMCS; National Ambulatory Medical Care Survey; PCP; primary care physician; PSA; prostate specific antigen;
Keywords: آنتی ژن اختصاصی پروستات; prostatic neoplasms; robotics; prostatectomy; magnetic resonance imaging; DCEI; dynamic contrast enhanced imaging; DRE; digital rectal examination; ECE; extracapsular extension; ERC; endorectal coil; MR; magnetic resonance; MRI; magnetic resonance imaging
Keywords: آنتی ژن اختصاصی پروستات; prostate; prostatic neoplasms; SEER program; Medicare; physician's practice patterns; AS; active surveillance; HMO; health maintenance organization; HRR; hospital referral region; PSA; prostate specific antigen; SEER; Surveillance, Epidemiology and End Re